A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Kevin S. Boyle Sr..

Business address: C/O Ziopharm Oncology, Inc., One First Avenue, Parris Bldg 34, Boston, MA, 02129
Top holdings (ownership): TCRT

Get insider transactions for this reporting owner

Kevin S. Boyle Sr. has filed 8 SEC EDGAR filings since 31 Aug 2021

Recent SEC filings for Kevin S. Boyle Sr. including 4, 144, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	05 Sep 2023	01 Sep 2023	001-33038
144	Open 144 document	View SEC filing for 144		01 Sep 2023
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	17 Mar 2023	15 Mar 2023	001-33038
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	01 Sep 2022	30 Aug 2022	001-33038
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	01 Apr 2022	30 Mar 2022	001-33038
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	17 Nov 2021	16 Nov 2021	001-33038
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	31 Aug 2021	30 Aug 2021	001-33038
3	Open 3 document	View SEC filing for 3	FORM 3 SUBMISSION	31 Aug 2021	30 Aug 2021	001-33038

Kevin S. Boyle Sr. files with the SEC under CIK 0001880600. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.